相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection
Manuel G. Feria-Garzon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy
V Mett et al.
ONCOGENE (2018)
Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis
Raja Atreya et al.
DIGESTIVE AND LIVER DISEASE (2018)
TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells
Rujuta A. Bam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Evidence of NI-0101 Pharmacological Activity, an Anti-TLR4 Antibody, in a Randomized Phase I Dose Escalation Study in Healthy Volunteers Receiving LPS
E. Monnet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
IL-10 INDUCTION PROPERTIES OF THE TLR-9 AGONIST COBITOLIMOD AND A CANDIDATE FOR TREATMENT OF ACTIVE ULCERATIVE COLITIS IN LATE STAGE OF CLINICAL DEVELOPMENT
Charlotte Admyre et al.
GASTROENTEROLOGY (2017)
Evaluation of Toll-like-receptor gene family variants as prognostic biomarkers in rheumatoid arthritis
Silvia Torices et al.
IMMUNOLOGY LETTERS (2017)
M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway
S. Aletaha et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
Abdelhabib Semlali et al.
ONCOTARGETS AND THERAPY (2017)
Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility
Chen Shuang et al.
ONCOTARGET (2017)
The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma
Jeong Hyun Cho et al.
ONCOTARGET (2017)
Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and susceptibility to pulmonary and peritoneal tuberculosis
Mohammed A. Saleh et al.
APMIS (2017)
TLR4 Asp299Gly polymorphism may be protective against chronic periodontitis
R. M. Sellers et al.
JOURNAL OF PERIODONTAL RESEARCH (2016)
TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models
Myriam Lamrani et al.
ONCOIMMUNOLOGY (2016)
Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state
Sarah A. Woller et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Vaccination in early life: standing up to the challenges
Elodie Mohr et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study
Matthew J. Worley et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Association of TLR9 polymorphism with overall survival in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab enrolled in FIRE3.
Satoshi Okazaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Association of TLR8 gene rs3764880 polymorphisms with susceptibility and lipid metabolism- and inflammation response-related quantitative traits of ischemic stroke in southern Chinese Han male population
Lian Gu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update
Y. H. Lee et al.
LUPUS (2016)
A common TLR1 polymorphism is associated with higher parasitaemia in a Southeast Asian population with Plasmodium falciparum malaria
William O. Hahn et al.
MALARIA JOURNAL (2016)
TLR4 polymorphism and periodontitis susceptibility: A meta-analysis
Su-Han Jin et al.
MEDICINE (2016)
Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial x Breast Cancer Hybrids, but Not in Parental Cells
Sabrina Fried et al.
PLOS ONE (2016)
Functional polymorphisms of the TLR7 and TLR8 genes contribute to Mycobacterium tuberculosis infection
Yung-Fa Lai et al.
TUBERCULOSIS (2016)
Toll-Like Receptor 11 (TLR11) Interacts with Flagellin and Profilin through Disparate Mechanisms
Hirotsugu Hatai et al.
PLOS ONE (2016)
Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
Stephen Delaney et al.
BMJ OPEN RESPIRATORY RESEARCH (2016)
CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation
Yang Xu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial
Ronald Levy et al.
BLOOD (2016)
CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study
T. B. Casale et al.
ALLERGY (2015)
A NOVEL SMALL MIMETIC MOLECULE TLR4 ANTAGONIST (IAXO-102) MODULATES TLR4 PROINFLAMMATORY SIGNALLING AND INHIBITS AORTIC ANEURYSMS DEVELOPMENT
C. L. Huggins et al.
ATHEROSCLEROSIS (2015)
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
Alain H. Rook et al.
BLOOD (2015)
Early Clinical Evaluation of the Intranasal TLR7 Agonist GSK2245035: Use of Translational Biomarkers to Guide Dosing and Confirm Target Engagement
D. Tsitoura et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside
Burghardt Wittig et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
IMPALA, a randomized phase III study in patients with metastatic colorectal carcinoma: Immunomodulatory maintenance therapy with TLR-9 agonist MGN1703.
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Toll-like Receptor Polymorphisms and Tuberculosis Susceptibility: A Comprehensive Meta-analysis
Qin Sun et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2015)
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study
Stefano Piaserico et al.
PHARMACOGENOMICS (2015)
Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis
Cristiano Xavier Lima et al.
PLOS ONE (2015)
Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis
Yang Cheng et al.
PLOS ONE (2015)
Synthesis of anti-inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4)
Peter Wipf et al.
TETRAHEDRON LETTERS (2015)
Association Between Antibiotic Exposure, Bronchiolitis, and TLR4 (rs1927911) Polymorphisms in Childhood Asthma
Eun Lee et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2015)
Vaccine adjuvant uses of poly-IC and derivatives
Karen Ao Martins et al.
EXPERT REVIEW OF VACCINES (2015)
STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes
Haishan Zhao et al.
MEDICAL ONCOLOGY (2015)
Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis
Naresh Kumar Meena et al.
PLOS ONE (2015)
Intratumoral Injection of TLR4 Agonist (G100) Leads to Tumor Regression of A20 Lymphoma and Induces Abscopal Responses
Idit Sagiv-Barfi et al.
BLOOD (2015)
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
David A. Smith et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
SA-4-1BBL and Monophosphoryl Lipid A Constitute an Efficacious Combination Adjuvant for Cancer Vaccines
Abhishek K. Srivastava et al.
CANCER RESEARCH (2014)
TLR1, TLR2, and TLR6 Gene Polymorphisms Are Associated With Increased Susceptibility to Complicated Skin and Skin Structure Infections
Mark H. T. Stappers et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival
K. Zeljic et al.
ORAL DISEASES (2014)
A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
Mark T. Orr et al.
PLOS ONE (2014)
Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice
Mohammad S. Hossain et al.
PLOS ONE (2014)
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
Charles Maisonneuve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China
Xin-su Wei et al.
YONSEI MEDICAL JOURNAL (2014)
Genuine Immunomodulation With dSLIM
Kerstin Kapp et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors
Nicolas Isambert et al.
BMC CANCER (2013)
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
M. Reilly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
A TLR6 polymorphism is associated with increased risk of Legionnaires' disease
E. A. Misch et al.
GENES AND IMMUNITY (2013)
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial
Steven M. Opal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
A Nonsense Polymorphism (R392X) in TLR5 Protects from Obesity but Predisposes to Diabetes
Nasser M. Al-Daghri et al.
JOURNAL OF IMMUNOLOGY (2013)
TLR agonists: our best frenemy in cancer immunotherapy
Sabina Kaczanowska et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
Miao Lin et al.
KIDNEY INTERNATIONAL (2013)
Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis
F. S. Belforte et al.
MOLECULAR BIOLOGY REPORTS (2013)
A Non-Synonymous Coding Variant (L616F) in the TLR5 Gene Is Potentially Associated with Crohn's Disease and Influences Responses to Bacterial Flagellin
Jared Sheridan et al.
PLOS ONE (2013)
Pollinex Quattro An innovative four injections immunotherapy in allergic rhinitis
Martin Rosewich et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Paul Sabbatini et al.
CLINICAL CANCER RESEARCH (2012)
MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
Elena Caproni et al.
JOURNAL OF IMMUNOLOGY (2012)
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
Theo S. Plantinga et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV
J. F. Bergmann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)
M. D. Fidock et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
TLR based therapeutics
Aisling Dunne et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Toll-like receptors on the fork roads between innate and adaptive immunity
Ahmed Abdelsadik et al.
HUMAN IMMUNOLOGY (2011)
TLR2-Dependent Induction of IL-10 and Foxp3+CD25+CD4+ Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
Sayuri Yamazaki et al.
PLOS ONE (2011)
Fundamentals of Vaccine Immunology
Angela S. Clem
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2011)
Antigen-Containing Liposomes Engrafted with Flagellin-Related Peptides Are Effective Vaccines That Can Induce Potent Antitumor Immunity and Immunotherapeutic Effect
Abdus Faham et al.
JOURNAL OF IMMUNOLOGY (2010)
A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
D. E. Spaner et al.
LEUKEMIA (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard et al.
MEDICINE (2010)
Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin
H. Keipp Talbot et al.
PLOS ONE (2010)
Protective Effects of Toll-like Receptor 4 Inhibitor Eritoran on Renal Ischemia-Reperfusion Injury
M. Liu et al.
TRANSPLANTATION PROCEEDINGS (2010)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
TLR3 Ligand Induces NF-κB Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-α Production
David Chiron et al.
JOURNAL OF IMMUNOLOGY (2009)
Implication of Activated Astrocytes in the Development of Drug Dependence Differences between Methamphetamine and Morphine
Minoru Narita et al.
ADDICTION REVIEWS 2008 (2008)
Toll-like receptor polymorphisms and susceptibility to human disease
E. Ann Misch et al.
CLINICAL SCIENCE (2008)
Structures of the toll-like receptor family and its ligand complexes
Mi Sun Jin et al.
IMMUNITY (2008)
Pyogenic bacterial infections in humans with MyD88 deficiency
Horst von Bernuth et al.
SCIENCE (2008)
Building an immune system from nine domains
E. M. Palsson-McDermott et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Sandra L. Giannini et al.
VACCINE (2006)
TLR signaling
T Kawai et al.
CELL DEATH AND DIFFERENTIATION (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Identification of high and low responders to lipopolysaccharide in normal subjects: An unbiased approach to identify modulators of innate immunity
MM Wurfel et al.
JOURNAL OF IMMUNOLOGY (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity
MJ LaVoie et al.
EXPERIMENTAL NEUROLOGY (2004)
Toll-like receptors in the pathogenesis of human disease
DN Cook et al.
NATURE IMMUNOLOGY (2004)
Innate immune recognition: mechanisms and pathways
R Medzhitov et al.
IMMUNOLOGICAL REVIEWS (2000)
分享论文
